Imagine a world where multiple sclerosis (MS) is no longer a life-altering diagnosis. That vision just got a little closer to reality. Australian scientists have achieved a groundbreaking milestone in MS research, unlocking the potential to study over 100 genetic risk factors simultaneously. This leap forward promises to revolutionize our understanding of how MS develops and, more importantly, how we can improve the lives of those affected by it.
Led by Dr. Hamish King at WEHI and fueled by a $2.8 million grant from MS Australia, this project tackles a long-standing mystery in MS genetics. While researchers have identified hundreds of DNA variations linked to MS risk over the past two decades, most don't directly alter genes. Instead, they subtly influence how genes are activated within immune cells, making their role in the disease incredibly complex to decipher. And this is the part most people miss: understanding how these genetic factors conspire to drive MS has been a major hurdle—until now.
Dr. King's team will introduce these genetic risk factors into human immune cells, meticulously observing how they individually and collectively impact gene activity and immune behavior. This innovative approach could pave the way for more targeted treatments and, ultimately, better long-term outcomes for people living with MS.
"For over 20 years, we've known about these genetic markers, but we've struggled to explain how they influence immune cell behavior," explains Dr. King. "MS often arises from the combined effect of many small genetic differences. This new platform allows us to study these changes collectively and pinpoint the specific genes and pathways they affect."
MS is an autoimmune condition where the body mistakenly attacks the brain and spinal cord, damaging the protective myelin sheath surrounding nerve fibers. This damage can impair mobility, vision, cognitive function, and energy levels. In 2025, over 37,700 Australians are living with MS—a staggering 77.4% increase since 2010. The economic burden of the disease reached $3 billion in 2024, underscoring the urgent need for accelerated research.
But here's where it gets controversial: while identifying genetic risk factors was a crucial first step, the real challenge lies in understanding how these changes actively drive the disease. Dr. Tennille Luker, MS Australia’s Head of Research, emphasizes, "Identifying risk was just the beginning. It's understanding how these genetic changes actually fuel the disease that allows us to alter its course."
MS Australia is also investing in research to slow disease progression, manage symptoms, and enhance quality of life. These efforts not only strengthen current responses to MS but also lay the groundwork for future prevention and cures. For instance, a Postdoctoral Fellowship funded by the Browne Family supports Dr. James Hilton at the University of Melbourne in developing compounds to protect nerve cells in progressive MS.
Over two decades, MS Australia has invested over $60 million in MS research. CEO Rohan Greenland highlights the importance of sustained national investment: "Research is hope. It reminds those living with MS that progress is possible and that better treatments and prevention are within reach."
The research grants will be officially launched at Parliament House in Canberra on March 4th during MS Australia’s Advancing MS Research in Australia event. Speakers, including Dr. Monique Ryan MP and Ms. Renee Coffey MP, will underscore the need for continued national commitment to MS research.
Featured Projects:
1. Sensory Shoe Insoles for Better Balance
Associate Professor Anna Hatton from The University of Queensland is developing innovative 'Vibrotexture' shoe insoles to enhance foot sensation and improve balance in MS patients. By boosting the signals sent from the feet to the brain, these insoles aim to reduce fall risk, support mobility, and boost everyday confidence. The goal is to create a globally accessible, clinically proven solution.
2. Protecting Brain Blood Flow to Slow MS
Professor Kaylene Young at the Menzies Institute for Medical Research is investigating how changes in brain blood vessels contribute to MS progression. Using stem cell models, her team will explore how genetic differences affect blood flow, inflammation, and nerve cell survival. The aim is to identify drug targets that protect myelin and slow disability progression.
3. Viral Triggers of MS
Mr. Alex Eisner from The Florey Institute of Neuroscience and Mental Health is examining how viruses like Epstein-Barr may influence MS by altering immune responses and gene expression. His project aims to clarify the molecular mechanisms linking viral infections to MS risk, progression, and treatment response. Could viruses be the missing piece in the MS puzzle? This research invites us to consider a controversial yet compelling possibility.
4. The Role of Copper in MS
Dr. Brittney Lins from Curtin University is exploring whether disrupted copper levels in the brain connect key MS risk factors, such as Epstein-Barr virus infection, vitamin D deficiency, and gut health. Her research will investigate whether copper imbalance contributes to myelin damage, potentially uncovering new prevention and treatment strategies.
These projects represent a beacon of hope for the MS community, offering a glimpse into a future where MS is not just manageable but preventable. What do you think? Are we on the cusp of a breakthrough, or is there still too much we don’t understand? Share your thoughts in the comments below!
